Image Ben Hargreaves Patients Cell and gene therapies and the tricky question of patient s... Cell and gene therapies represent the cutting edge of pharma technology, but how are patients experiencing this treatment revolution? R&D Non-opioid painkillers: Another tool to fight the opioid epi... The opioid epidemic is still an ongoing problem and there is no single solution to bring it under control. Patients FDA wants to make the home a healthcare hub During the pandemic, the world became accustomed to carrying out more activities from the home, including healthcare needs. Market Access US-Chinese relations put the brakes on biotech cooperation The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing. Load more results
Patients Cell and gene therapies and the tricky question of patient s... Cell and gene therapies represent the cutting edge of pharma technology, but how are patients experiencing this treatment revolution?
R&D Non-opioid painkillers: Another tool to fight the opioid epi... The opioid epidemic is still an ongoing problem and there is no single solution to bring it under control.
Patients FDA wants to make the home a healthcare hub During the pandemic, the world became accustomed to carrying out more activities from the home, including healthcare needs.
Market Access US-Chinese relations put the brakes on biotech cooperation The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
